| |
|
|
Proteomic non-small cell lung carcinoma biomarker screening in bronchoalveolar lavage fluid
1 Institute of Cell and Molecular Pathology - 2 Department of Toxicology, Hannover Medical School MHH 3 Respiratory Medicine Department of Internal Medicine I, University Hospital Halle, Halle (Saale)
Using a standardized method to acquire MALDI-TOF proteome profile spectra of bronchoalveolar lavage fluid (BALF), we have shown the upregulation of histatin 3 and calgranulin C in a small pilot cohort of NSCLC patients. This pilot study serves to demonstrate that it is feasible to screen a larger NSCLC patient cohort for BALF proteome level biomarkers in a clinical setting.
|
Chemically Modified Primers for Improved Multiplexed PCR
TriLink BioTechnologies
Multiplex PCR is an advantageous technique used in PCR applications to amplify multiple targets in a single reaction. As useful as it is, this technique presents a new set of challenges that further complicates PCR setup. For example, reactions are more prone to off-target amplifications such as mis-priming and primer dimer due to the increased number of primer pairs. Furthermore, preferential amplification of certain targets leads to an unequal distribution of amplicon products, making quantifi
|
|
|
|
|
|
Post-doctoral position at INRA (France)
INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants.
|
|
|
Engineer Technician, Fayetteville, Arizona, USA
SFC-Fluidics
SFC Fluidics is looking to hire a highly motivated, detail-oriented engineer technician.
oral communication skills . Experience with GMP and GLP desired
|
|
|
Computational Medicinal Chemistry Post-Doc Position, Siena, Italy
University of Siena
NatSynDrugs Is Seeking Candidates For a Computational Medicinal Chemistry Post-Doc Position
|
|
|
Program Development Manager, LasX Industries, MN, USA
LasX Industries
The position of Program Development Manager assumes the lead role for developing production processes for targeted programs, primarily in the micro-fluidics market.
|
|
|
Automation Engineer, Metabolism, Agios Pharmaceuticals, Cambridge, MA, USA
Agios Pharmaceuticals
With new research showing that cancer cells become addicted to using more nutrients than normal cells to promote their rapid growth, there is an unprecedented opportunity to create a new class of oncology therapeutics that target a fundamental and ubiquitous mechanism in cancer cells. The intersection of these two fields of research - cancer and metabolism- represents an important and novel approach to treating cancer.
|
|
|
Senior Scientist, Metabolism
Agios
Agios Pharmaceuticals is seeking a PhD Scientist to join a team that is building and applying a state-of-art approach to investigate the intersection of cancer cell biology and metabolism.
|
|
|
Metabolomics Platform Coordinator, CIBERDEM, Barcelona
CIBERDEM
The Metabolomics Platform is a research facility financed by CIBERDEM, the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders. CIBERDEM is an initiative of the Carlos III Health Institute (Ministry of Science and Innovation, http://www.isciii.es), while the platform is located at the Universitat Rovira i Virgili (Tarragona, Spain).
|
|
|
Senior Fellow, Long Term Research in Metabolomics and Nutrient
PepsiCo
Establish and lead the LTR Pepsico Biology Innovation Lab (PIBL) Metabolomics and Nutrient Physiology research program and team.
|
|
|
US Field Application Scientist, Cell based assay technology
Langton Howarth
Our client supplies novel laboratory scale instrumentation, screening services and develops custom automation for life sciences companies spanning the healthcare, biotech and pharmaceutical sectors.
Due to expansion they now seek a US Field Application Scientist to support sales and customers of their high content screening/cell based assay technology.
|
|
|
Compound Management Technologist, St Jude Children's Research Hospital, Memphis, TN
St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. St. Jude is dedicated to providing unsurpassed patient care and to advancing the health of children through biomedical research.
|
|
|
Postdoctoral Research Associate
Northeastern University
The Center for Drug Discovery at Northeastern University is dedicated to designing and discovering novel medications, developing technologies, and training scientists in the multidisciplinary field of drug discovery. We are recruiting a Postdoctoral Research Associate with expertise in protein-based mass spectrometry and /or proteomics.
|
|
|
Assistant/Associate Professors
Chinese University of Hong Kong
The newly established School of Biomedical Sciences, Stem Cell and Regeneration theme is actively looking for stem cell biologist over the next 2 years.
|
|
|
Marketing Communications Specialist Position in San Jose, CA
Thermo Fisher Scientific
This position, based in San Jose, CA within the SID Division, will manage promotion of Thermo Scientific mass spectrometry products and services.
|
|
|
|
Cancer Genomics & Cancer Mutations
02 August 2010 - 04 August 2010
Personalizing Cancer Medicine: Strategies for Drug and Diagnostic Development
Learn more about:
• New approaches for targeting cancers and personalizing treatment regimens
• Exploiting the expressed tumor genome and DNA structure/sequence
• Breaking news from cancer genome consortia and clinical projects
Register at www.IBCLifeSciences.com/cancergenomics, save 20% off standard rates, use priority code: D10201TN.
|
Cancer Stem Cells & the Tumor Microenvironment
02 August 2010 - 04 August 2010
Exploiting CSC's, Inflammation and Stromal Support of Tumors for Therapeutic Intervention
Learn more about:
• Therapeutics targeting the inflammatory component of tumors
• Data from cancer stem cell-targeted drugs in development
• New insights on stromal support of tumors and the tumor microenvironment
Register at www.IBCLifeSciences.com/cancermicro, save 20% off standard rates, use priority code: D10201TN.
|
BIOTECHNICA Hannover, Germany
05 October 2010 - 07 October 2010
BIOTECHNICA is one of Europe's top annual meeting places for the biotech and life science industry. Here you meet target groups you would never reach at a conventional trade fair thanks to an extensive conference programme that attracts a high calibre of visitors.
|
Personalised Medicine
11 October 2010 - 12 October 2010
Attend SMi’s 2010 Personalised Medicine conference to study the latest developments in the science and the latest business strategies and partnership models moving the industry nearer to a personalised future.
To get more information on this conference please visit www.smi-online.co.ukl/personalised11.asp
|
|
|
|
|
|
|
The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine
Business Insights
This report analyzes the current and potential world markets for molecular diagnostics, including advances in the field. This report generally forecasts future growth to 2015. The report breaks down market forecasts by type of test and by geography. It indicates which companies have key products in the market place. It also analyzes key drivers of this market.
|
Molecular Diagnostics Market: Trends and Opportunities
Koncept Analytics
Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry. In the decision making process of healthcare experts, diagnostics tests have a major influence.
|
|
|